203 related articles for article (PubMed ID: 27025828)
1. Mortality According to CD4 Count at Start of Combination Antiretroviral Therapy Among HIV-infected Patients Followed for up to 15 Years After Start of Treatment: Collaborative Cohort Study.
May MT; Vehreschild JJ; Trickey A; Obel N; Reiss P; Bonnet F; Mary-Krause M; Samji H; Cavassini M; Gill MJ; Shepherd LC; Crane HM; d'Arminio Monforte A; Burkholder GA; Johnson MM; Sobrino-Vegas P; Domingo P; Zangerle R; Justice AC; Sterling TR; Miró JM; Sterne JAC; ; Boulle A; Stephan C; Miro JM; Cavassini M; Chêne G; Costagliola D; Dabis F; Monforte AD; Del Amo J; Van Sighem A; Fätkenheuer G; Gill J; Guest J; Haerry DH; Hogg R; Justice A; Shepherd L; Obel N; Crane H; Smith C; Reiss P; Saag M; Sterling T; Teira R; Williams M; Zangerle R; Sterne J; May M; Ingle S; Trickey A
Clin Infect Dis; 2016 Jun; 62(12):1571-1577. PubMed ID: 27025828
[TBL] [Abstract][Full Text] [Related]
2. Mortality of HIV-infected patients starting potent antiretroviral therapy: comparison with the general population in nine industrialized countries.
; Zwahlen M; Harris R; May M; Hogg R; Costagliola D; de Wolf F; Gill J; Fätkenheuer G; Lewden C; Saag M; Staszewski S; d'Arminio Monforte A; Casabona J; Lampe F; Justice A; von Wyl V; Egger M
Int J Epidemiol; 2009 Dec; 38(6):1624-33. PubMed ID: 19820106
[TBL] [Abstract][Full Text] [Related]
3. CD4:CD8 Ratio and CD8 Count as Prognostic Markers for Mortality in Human Immunodeficiency Virus-Infected Patients on Antiretroviral Therapy: The Antiretroviral Therapy Cohort Collaboration (ART-CC).
Trickey A; May MT; Schommers P; Tate J; Ingle SM; Guest JL; Gill MJ; Zangerle R; Saag M; Reiss P; Monforte AD; Johnson M; Lima VD; Sterling TR; Cavassini M; Wittkop L; Costagliola D; Sterne JAC;
Clin Infect Dis; 2017 Sep; 65(6):959-966. PubMed ID: 28903507
[TBL] [Abstract][Full Text] [Related]
4. Cotrimoxazole prophylaxis and antiretroviral therapy: an observational cohort study in China.
Cheng W; Wu Y; Wen Y; Ma Y; Zhao D; Dou Z; Zhang W; Bulterys M; Zhang F
Bull World Health Organ; 2015 Mar; 93(3):152-60. PubMed ID: 25838611
[TBL] [Abstract][Full Text] [Related]
5. Heterogeneity in outcomes of treated HIV-positive patients in Europe and North America: relation with patient and cohort characteristics.
May MT; Hogg RS; Justice AC; Shepherd BE; Costagliola D; Ledergerber B; Thiébaut R; Gill MJ; Kirk O; van Sighem A; Saag MS; Navarro G; Sobrino-Vegas P; Lampe F; Ingle S; Guest JL; Crane HM; D'Arminio Monforte A; Vehreschild JJ; Sterne JA;
Int J Epidemiol; 2012 Dec; 41(6):1807-20. PubMed ID: 23148105
[TBL] [Abstract][Full Text] [Related]
6. Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies.
; Sterne JA; May M; Costagliola D; de Wolf F; Phillips AN; Harris R; Funk MJ; Geskus RB; Gill J; Dabis F; Miró JM; Justice AC; Ledergerber B; Fätkenheuer G; Hogg RS; Monforte AD; Saag M; Smith C; Staszewski S; Egger M; Cole SR
Lancet; 2009 Apr; 373(9672):1352-63. PubMed ID: 19361855
[TBL] [Abstract][Full Text] [Related]
7. Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies.
Antiretroviral Therapy Cohort Collaboration
Lancet HIV; 2017 Aug; 4(8):e349-e356. PubMed ID: 28501495
[TBL] [Abstract][Full Text] [Related]
8. Prognosis of patients with HIV-1 infection starting antiretroviral therapy in sub-Saharan Africa: a collaborative analysis of scale-up programmes.
May M; Boulle A; Phiri S; Messou E; Myer L; Wood R; Keiser O; Sterne JA; Dabis F; Egger M;
Lancet; 2010 Aug; 376(9739):449-57. PubMed ID: 20638120
[TBL] [Abstract][Full Text] [Related]
9. Impact on life expectancy of HIV-1 positive individuals of CD4+ cell count and viral load response to antiretroviral therapy.
May MT; Gompels M; Delpech V; Porter K; Orkin C; Kegg S; Hay P; Johnson M; Palfreeman A; Gilson R; Chadwick D; Martin F; Hill T; Walsh J; Post F; Fisher M; Ainsworth J; Jose S; Leen C; Nelson M; Anderson J; Sabin C;
AIDS; 2014 May; 28(8):1193-202. PubMed ID: 24556869
[TBL] [Abstract][Full Text] [Related]
10. Cause-Specific Mortality in HIV-Positive Patients Who Survived Ten Years after Starting Antiretroviral Therapy.
Trickey A; May MT; Vehreschild J; Obel N; Gill MJ; Crane H; Boesecke C; Samji H; Grabar S; Cazanave C; Cavassini M; Shepherd L; d'Arminio Monforte A; Smit C; Saag M; Lampe F; Hernando V; Montero M; Zangerle R; Justice AC; Sterling T; Miro J; Ingle S; Sterne JA;
PLoS One; 2016; 11(8):e0160460. PubMed ID: 27525413
[TBL] [Abstract][Full Text] [Related]
11. Renal dysfunction by baseline CD4 cell count in a cohort of adults starting antiretroviral treatment regardless of CD4 count in the HIV Prevention Trials Network 071 [HPTN 071; Population Effect of Antiretroviral Therapy to Reduce HIV Transmission (PopART)] study in South Africa.
Bock P; Nel K; Fatti G; Sloot R; Ford N; Voget J; Gunst C; Grobbelaar N; Louis F; Floyd S; Hayes R; Ayles H; Beyers N; Fidler S;
HIV Med; 2019 Jul; 20(6):392-403. PubMed ID: 30963667
[TBL] [Abstract][Full Text] [Related]
12. A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa.
; Danel C; Moh R; Gabillard D; Badje A; Le Carrou J; Ouassa T; Ouattara E; Anzian A; Ntakpé JB; Minga A; Kouame GM; Bouhoussou F; Emieme A; Kouamé A; Inwoley A; Toni TD; Ahiboh H; Kabran M; Rabe C; Sidibé B; Nzunetu G; Konan R; Gnokoro J; Gouesse P; Messou E; Dohoun L; Kamagate S; Yao A; Amon S; Kouame AB; Koua A; Kouamé E; Ndri Y; Ba-Gomis O; Daligou M; Ackoundzé S; Hawerlander D; Ani A; Dembélé F; Koné F; Guéhi C; Kanga C; Koule S; Séri J; Oyebi M; Mbakop N; Makaila O; Babatunde C; Babatounde N; Bleoué G; Tchoutedjem M; Kouadio AC; Sena G; Yededji SY; Assi R; Bakayoko A; Mahassadi A; Attia A; Oussou A; Mobio M; Bamba D; Koman M; Horo A; Deschamps N; Chenal H; Sassan-Morokro M; Konate S; Aka K; Aoussi E; Journot V; Nchot C; Karcher S; Chaix ML; Rouzioux C; Sow PS; Perronne C; Girard PM; Menan H; Bissagnene E; Kadio A; Ettiegne-Traore V; Moh-Semdé C; Kouame A; Massumbuko JM; Chêne G; Dosso M; Domoua SK; N'Dri-Yoman T; Salamon R; Eholié SP; Anglaret X
N Engl J Med; 2015 Aug; 373(9):808-22. PubMed ID: 26193126
[TBL] [Abstract][Full Text] [Related]
13. Life expectancy after 2015 of adults with HIV on long-term antiretroviral therapy in Europe and North America: a collaborative analysis of cohort studies.
Trickey A; Sabin CA; Burkholder G; Crane H; d'Arminio Monforte A; Egger M; Gill MJ; Grabar S; Guest JL; Jarrin I; Lampe FC; Obel N; Reyes JM; Stephan C; Sterling TR; Teira R; Touloumi G; Wasmuth JC; Wit F; Wittkop L; Zangerle R; Silverberg MJ; Justice A; Sterne JAC
Lancet HIV; 2023 May; 10(5):e295-e307. PubMed ID: 36958365
[TBL] [Abstract][Full Text] [Related]
14. Observed CD4 counts at entry into HIV care and at antiretroviral therapy prescription by age in the USA, 2004-18: a cohort study.
Lee JS; Humes E; Hogan BC; Justice AC; Klein M; Gebo K; John Gill M; Silverberg MJ; Rebeiro P; Horberg M; Karris M; Rabkin C; Moore RD; Althoff KN;
Lancet HIV; 2022 Mar; 9 Suppl 1():S2. PubMed ID: 35304844
[TBL] [Abstract][Full Text] [Related]
15. Life expectancy of persons receiving combination antiretroviral therapy in low-income countries: a cohort analysis from Uganda.
Mills EJ; Bakanda C; Birungi J; Chan K; Ford N; Cooper CL; Nachega JB; Dybul M; Hogg RS
Ann Intern Med; 2011 Aug; 155(4):209-16. PubMed ID: 21768555
[TBL] [Abstract][Full Text] [Related]
16. Predictors of trend in CD4-positive T-cell count and mortality among HIV-1-infected individuals with virological failure to all three antiretroviral-drug classes.
Ledergerber B; Lundgren JD; Walker AS; Sabin C; Justice A; Reiss P; Mussini C; Wit F; d'Arminio Monforte A; Weber R; Fusco G; Staszewski S; Law M; Hogg R; Lampe F; Gill MJ; Castelli F; Phillips AN;
Lancet; 2004 Jul 3-9; 364(9428):51-62. PubMed ID: 15234856
[TBL] [Abstract][Full Text] [Related]
17. Effects of Antiretroviral Therapy on the Survival of Human Immunodeficiency Virus-positive Adult Patients in Andhra Pradesh, India: A Retrospective Cohort Study, 2007-2013.
Bajpai R; Chaturvedi H; Jayaseelan L; Harvey P; Seguy N; Chavan L; Raj P; Pandey A
J Prev Med Public Health; 2016 Nov; 49(6):394-405. PubMed ID: 27951632
[TBL] [Abstract][Full Text] [Related]
18. Mortality and its predictors among antiretroviral therapy naïve HIV-infected individuals with CD4 cell count ≥350 cells/mm(3) compared to the general population: data from a population-based prospective HIV cohort in Uganda.
Masiira B; Baisley K; Mayanja BN; Kazooba P; Maher D; Kaleebu P
Glob Health Action; 2014; 7():21843. PubMed ID: 24433941
[TBL] [Abstract][Full Text] [Related]
19. Impact of risk factors for specific causes of death in the first and subsequent years of antiretroviral therapy among HIV-infected patients.
Ingle SM; May MT; Gill MJ; Mugavero MJ; Lewden C; Abgrall S; Fätkenheuer G; Reiss P; Saag MS; Manzardo C; Grabar S; Bruyand M; Moore D; Mocroft A; Sterling TR; D'Arminio Monforte A; Hernando V; Teira R; Guest J; Cavassini M; Crane HM; Sterne JA;
Clin Infect Dis; 2014 Jul; 59(2):287-97. PubMed ID: 24771333
[TBL] [Abstract][Full Text] [Related]
20. Gender differences in survival among adult patients starting antiretroviral therapy in South Africa: a multicentre cohort study.
Cornell M; Schomaker M; Garone DB; Giddy J; Hoffmann CJ; Lessells R; Maskew M; Prozesky H; Wood R; Johnson LF; Egger M; Boulle A; Myer L;
PLoS Med; 2012; 9(9):e1001304. PubMed ID: 22973181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
